{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T03:49:22Z","timestamp":1769572162278,"version":"3.49.0"},"publisher-location":"Dordrecht","reference-count":25,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789400745452","type":"print"},{"value":"9789400745469","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T00:00:00Z","timestamp":1340323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-94-007-4546-9_38","type":"book-chapter","created":{"date-parts":[[2012,7,23]],"date-time":"2012-07-23T09:47:38Z","timestamp":1343036858000},"page":"299-305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Pulmonary Arterial Hypertension in Patients with Sarcoidosis: The Pulsar Single Center Experience"],"prefix":"10.1007","author":[{"given":"Stefan","family":"Pabst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Hammerstingl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Grau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Kreuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Grohe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe R.","family":"Juergens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Nickenig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Skowasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,22]]},"reference":[{"key":"38_CR1","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1378\/chest.08-1881","volume":"135","author":"CF Barnett","year":"2009","unstructured":"Barnett, C. F., Bonura, E. J., Nathan, S. D., Ahmad, S., Shlobin, O. A., Osei, K., Zaiman, A. L., Hassoun, P. M., Moller, D. R., Barnett, S. D., & Girgis, R. E. (2009). Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience. Chest, 135, 1455\u20131461.","journal-title":"Chest"},{"issue":"Suppl. 2","key":"38_CR2","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1186\/ar2192","volume":"9","author":"RP Baughman","year":"2007","unstructured":"Baughman, R. P. (2007). Pulmonary hypertension associated with sarcoidosis. Arthritis Research & Therapy, 9(Suppl. 2), S8.","journal-title":"Arthritis Research & Therapy"},{"key":"38_CR3","first-page":"108","volume":"23","author":"RP Baughman","year":"2006","unstructured":"Baughman, R. P., Engel, P. J., Meyer, C. A., Barrett, A. B., & Lower, E. E. (2006). Pulmonary hypertension in sarcoidosis. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 23, 108\u2013116.","journal-title":"Sarcoidosis, Vasculitis, and Diffuse Lung Diseases"},{"key":"38_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1378\/chest.06-2822","volume":"132","author":"RP Baughman","year":"2007","unstructured":"Baughman, R. P., Sparkman, B. K., & Lower, E. E. (2007). Six-minute walk test and health status assessment in sarcoidosis. Chest, 132, 207\u2013213.","journal-title":"Chest"},{"key":"38_CR5","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1378\/chest.09-2002","volume":"138","author":"RP Baughman","year":"2010","unstructured":"Baughman, R. P., Engel, P. J., Taylor, L., & Lower, E. E. (2010). Survival in sarcoidosis-associated pulmonary hypertension: The importance of hemodynamic evaluation. Chest, 138, 1078\u20131085.","journal-title":"Chest"},{"key":"38_CR6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1183\/09031936.00175907","volume":"32","author":"JM Bourbonnais","year":"2008","unstructured":"Bourbonnais, J. M., & Samavati, L. (2008). Clinical predictors of pulmonary hypertension in sarcoidosis. European Respiratory Journal, 32, 296\u2013302.","journal-title":"European Respiratory Journal"},{"key":"38_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1440-1843.2010.01872.x","volume":"16","author":"TJ Corte","year":"2011","unstructured":"Corte, T. J., Wells, A. U., Nicholson, A. G., Hansell, D. M., & Wort, S. J. (2011). Pulmonary hypertension in sarcoidosis. A review. Respirology, 16, 69\u201377.","journal-title":"Respirology"},{"key":"38_CR8","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1378\/chest.130.5.1481","volume":"130","author":"KA Fisher","year":"2006","unstructured":"Fisher, K. A., Serlin, D. M., Wilson, K. C., Walter, R. E., Berman, J. S., & Farber, H. W. (2006). Sarcoidosis-associated pulmonary hypertension: Outcome with long-term epoprostenol treatment. Chest, 130, 1481\u20131488.","journal-title":"Chest"},{"key":"38_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000089815","volume":"75","author":"RJ Foley","year":"2008","unstructured":"Foley, R. J., & Metersky, M. L. (2008). Successful treatment of sarcoidosis-associated pulmonary hypertension with bosentan. Respiration, 75, 211\u2013214.","journal-title":"Respiration"},{"key":"38_CR24","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1183\/09031936.00139009","volume":"34","author":"N Gali\u00e8","year":"2009","unstructured":"Gali\u00e8, N., Humbert, M., Torbicki, A., Vachiery, J. L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., Gibbs, J. S., Gomez-Sanchez, M. A., Jondeau, G., Klepetko, W., Opitz, C., Peacock, A., Rubin, L., Zellweger, M., & Simonneau, G. (2009). Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT), Guidelines for the diagnosis and treatment of pulmonary hypertension. European Respiratory Journal, 34, 1219\u20131263.","journal-title":"European Respiratory Journal"},{"key":"38_CR10","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1378\/chest.129.5.1246","volume":"129","author":"T Handa","year":"2006","unstructured":"Handa, T., Nagai, S., Miki, S., Fushimi, Y., Ohta, K., Mishima, M., & Izumi, T. (2006). Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest, 129, 1246\u20131252.","journal-title":"Chest"},{"key":"38_CR11","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","volume":"173","author":"M Humbert","year":"2006","unstructured":"Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaici, A., Weitzenblum, E., Cordier, J. F., Chabot, F., Dromer, C., Pison, C., Reynaud-Gaubert, M., Haloun, A., Laurent, M., Hachulla, E., & Simonneau, G. (2006). Pulmonary arterial hypertension in France: Results from a national registry. American Journal of Respiratory and Critical Care Medicine, 173, 1023\u20131030.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"38_CR011","unstructured":"Hunninghake, G. W., Costabel, U., Ando, M., Baughman, R., Cordier, J. F., du Bois, R., Eklund, A., Kitaichi, M., Lynch, J., Rizzato, G., Rose, C., Selroos, O., Semenzato, G., Sharma, O.P. (1999). ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis, vasculitis, and diffuse lung diseases, 16, 149\u2013172."},{"key":"38_CR12","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi, M. C., Rybicki, B. A., & Teirstein, A. S. (2007). Sarcoidosis. The New England Journal of Medicine, 357, 2153\u20132165.","journal-title":"The New England Journal of Medicine"},{"key":"38_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.healun.2007.11.576","volume":"27","author":"N Milman","year":"2008","unstructured":"Milman, N., Burton, C. M., Iversen, M., Videbaek, R., Jensen, C. V., & Carlsen, J. (2008). Pulmonary hypertension in end-stage pulmonary sarcoidosis: Therapeutic effect of sildenafil? The Journal of Heart and Lung Transplantation, 27, 329\u2013334.","journal-title":"The Journal of Heart and Lung Transplantation"},{"key":"38_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1136\/thx.2005.042838","volume":"61","author":"H Nunes","year":"2006","unstructured":"Nunes, H., Humbert, M., Capron, F., Brauner, M., Sitbon, O., Battesti, J. P., Simonneau, G., & Valeyre, D. (2006). Pulmonary hypertension associated with sarcoidosis: Mechanisms, haemodynamics and prognosis. Thorax, 61, 68\u201374.","journal-title":"Thorax"},{"key":"38_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1183\/09031936.00120410","volume":"38","author":"S Pabst","year":"2010","unstructured":"Pabst, S., Fr\u00e4nken, T., Sch\u00f6nau, J., Stier, S., Nickenig, G., Meyer, R., Skowasch, D., & Groh\u00e9, C. (2010). Transforming growth factor beta gene polymorphisms in different phenotypes of sarcoidosis. European Respiratory Journal, 38, 169\u2013175.","journal-title":"European Respiratory Journal"},{"key":"38_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/1753465809341650","volume":"3","author":"GG Pitsiou","year":"2009","unstructured":"Pitsiou, G. G., Spyratos, D., Kioumis, I., Boutou, A. K., Nakou, C., & Stanopoulos, I. (2009). Sarcoidosis-associated pulmonary hypertension: A role for endothelin receptor antagonists? Therapeutic Advances in Respiratory Disease, 3, 99\u2013101.","journal-title":"Therapeutic Advances in Respiratory Disease"},{"key":"38_CR17","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1378\/chest.120.3.866","volume":"120","author":"IR Preston","year":"2001","unstructured":"Preston, I. R., Klinger, J. R., Landzberg, M. J., Houtchens, J., Nelson, D., & Hill, N. S. (2001). Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension. Chest, 120, 866\u2013872.","journal-title":"Chest"},{"key":"38_CR18","first-page":"121","volume":"64","author":"G Rizzato","year":"1983","unstructured":"Rizzato, G., Pezzano, A., Sala, G., Merlini, R., Ladelli, L., Tansini, G., Montanari, G., & Bertoli, L. (1983). Right heart impairment in sarcoidosis: Haemodynamic and echocardiographic study. European Journal of Respiratory Diseases, 64, 121\u2013128.","journal-title":"European Journal of Respiratory Diseases"},{"key":"38_CR19","first-page":"405","volume":"32","author":"S Sharma","year":"2005","unstructured":"Sharma, S., Kashour, T., & Philipp, R. (2005). Secondary pulmonary arterial hypertension: Treated with endothelin receptor blockade. Texas Heart Institute Journal, 32, 405\u2013410.","journal-title":"Texas Heart Institute Journal"},{"key":"38_CR20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1183\/09031936.05.00083404","volume":"25","author":"AF Shorr","year":"2005","unstructured":"Shorr, A. F., Helman, D. L., Davies, D. B., & Nathan, S. D. (2005). Pulmonary hypertension in advanced sarcoidosis: Epidemiology and clinical characteristics. European Respiratory Journal, 25, 783\u2013788.","journal-title":"European Respiratory Journal"},{"issue":"Suppl 1","key":"38_CR21","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","volume":"54","author":"G Simonneau","year":"2009","unstructured":"Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z. C., Krowka, M. J., Langleben, D., Nakanishi, N., & Souza, R. (2009). Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology, 54(Suppl 1), S43\u2013S54.","journal-title":"Journal of the American College of Cardiology"},{"key":"38_CR22","unstructured":"Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee. 1999. American Journal of Respiratory and Critical Care Medicine, 160, 736\u201355."},{"key":"38_CR23","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1378\/chest.128.3.1483","volume":"128","author":"R Sulica","year":"2005","unstructured":"Sulica, R., Teirstein, A. S., Kakarla, S., Nemani, N., Behnegar, A., & Padilla, M. L. (2005). Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Chest, 128, 1483\u20131489.","journal-title":"Chest"}],"container-title":["Advances in Experimental Medicine and Biology","Respiratory Regulation - Clinical Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-007-4546-9_38","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T16:56:43Z","timestamp":1558457803000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-94-007-4546-9_38"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,22]]},"ISBN":["9789400745452","9789400745469"],"references-count":25,"URL":"https:\/\/doi.org\/10.1007\/978-94-007-4546-9_38","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6,22]]},"assertion":[{"value":"22 June 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}